ICAM1 and breast carcinoma: However, despite being able to kill TNBC cells effectively in vitro and showing an improved migration profile, MMP14-engineered γδ T cells could not eliminate TNBC tumors in vivo due to down regulation of γδ T cell ligands Fas, MICB and intercellular adhesion molecule 1 (ICAM-1) on breast cancer stem cells.